Editorial American Journal of Cancer Research Editorial Board (2011)

3 downloads 875 Views 85KB Size Report
Jun 30, 2011 - Dana-Farber Cancer Institute Harvard Medical School ... Dietmar W. Siemann, PhD, University of Florida Shands Cancer Center, Gainesville, FL, USA ... Nils Cordes, MD, Dresden University of Technology, Dresden, Germany.
Am J Cancer Res 2011;1(6):817-822 www.ajcr.us /ISSN: 2160-1992/AJBR1105000

Editorial American Journal of Cancer Research Editorial Board (2011) e-Century Publishing Corporation Received June 25, 2011; Accepted June 25, 2011; Epub: June 28, 2011; Published June 30, 2011

Editor-in-Chief

Associate Editor-in-Chief

Joseph H. Antin, MD, Dana-Farber Cancer Institute Harvard Medical School Boston, MA, USA

Michael R. Emmert-Buck, MD, PhD National Cancer Institute Maryland, MD, USA

Associate Editor-in-Chief

Associate Editor-in-Chief

Andrew E. Aplin, PhD, Thomas Jefferson University Philadelphia, PA, USA

Vincent L. Cryns, MD Northwestern University Chicago, IL, USA

Associate Editor-in-Chief

Associate Editor-in-Chief

Sheue-yann Cheng, PhD, National Cancer Institute Bethesda, MD, USA

Dengshun Wang, MD, PhD University of Wisconsin Madison, WI, USA

Founding Editorial Board Bharat B. Aggarwal, PhD,The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA David D. Bowtell, PhD, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Austraia Ting-Chao Chou, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Mien-Chie Hung, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Roy A. Jensen, MD, University of Kansas Cancer Center, Kansas City, KS, USA Guido Kroemer, MD, PhD, University Paris 5 Rene Descartes, Paris, France Christopher J. Logothetis, MD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Lucio Miele, MD, PhD, Cancer Institute, the University of Mississippi Medical Center, Jackson, MS, USA Stephen Safe, PhD, Texas A&M Health Science Center, College Station, TX, USA Michael J. Seckl, PhD, Molecular Cancer Medicine and Lung Cancer Biology, Imperial College London, London, UK Dietmar W. Siemann, PhD, University of Florida Shands Cancer Center, Gainesville, FL, USA Anil K. Sood, MD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Joseph R. Testa, PhD, Fox Chase Cancer Center, Philadelphia, PA, USA Axel Ullrich, PhD, Max Planck Institute of Biochemistry, Martinsried, Germany

Senior Editorial Board Lucia Altucci, MD, PhD, Department of General Pathology, Second University of Naples, Naples, ltaly Kiyoshi Ariizumi, PhD, Department of Dermatology, University of Texas Southwestern, Dallas, Texas, USA Joaquín V. Arribas López, PhD, Vall d'Hebron Institute of Oncology, Barcelona, Spain Patrick Auberger, PhD, Mediterranean Center for Molecular Medicine, University of Nice Sophia-Antipolis, France Suk-Chul Bae, PhD, Institute for Tumor Research, Chungbuk National University, Cheongju, South Korea Dave Bates, PhD, Microvascular Research and Medicine, University of Bristol, Bristol, UK

Editorial Board 2011

Surinder K. Batra, PhD, Eppley Cancer Institute, University of Nebraska, Omaha, NE, USA Yaacov Ben-David, PhD, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada Steven J. Berberich, PhD, Department of Biochemistry & Molecular Biology, Wright State University, Dayton, OH, USA Stephen A. Boppart, MD, PhD, University of Illinois at Urbana-Champaign, IL, USA Matthew E. Burow, PhD, Tulane University School of Medicine, New Orleans, LA, USA Sjoerd H. van der Burg, PhD, Department of Clinical Oncology, Leiden University Medical Center, The Netherlands. Qiuyin Cai, MD, PhD, Vanderbilt University School of Medicine, Nashville, TN, USA Giovanni Camussi, MD, Department of Internal Medicine, University of Torino, Torino, Italy Federica Cavallo, PhD, Molecular Biotechnology Center, University of Turin, Turin, Italy Christophe Cazaux, PhD, University of Toulouse,Tououse Cedex, France Preet M. Chaudhary, MD, PhD, University of Southern California, Los Angeles, CA, USA Zhong Chen, MD, PhD, National Institute on Deafness and other Communication Disorders, NIH, Bethesda, MD, USA Fei Chen, PhD, Wayne State University, Detroit, MI, USA Guan Chen, MD, PhD, Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA Hongwu Chen, PhD, University of Calfornia at Davis, Davis, CA, USA Roberto Chiarle, PhD, Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Itlay Paola Chiarugi, PhD, Department of Biochemical Sciences, University of Florence, Italy Lucian R. Chirieac, MD, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA Namhoon Cho, MD, Department of Pathology, Yonsei University College of Medicine, Yonsei, Korea Leland W. K. Chung, PhD, Cedars-Sinai Medical Center, Los Angeles, CA, USA Francois X. Claret, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA John A. Copland, PhD, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA Nils Cordes, MD, Dresden University of Technology, Dresden, Germany Max Costa, PhD, NYU Cancer Center, New York University, New York, NY, USA José Courty, PhD, University Paris EST, Paris, France Vincent L. Cryns, MD, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Olivier Cuvillier, PhD, Institute of Pharmacology and Structural Biology, Toulouse Cedex, France Shanaz H. Dairkee, PhD, California Pacific Medical Center Research Institute, San Francisco, CA, USA Ramana Davuluri, PhD, The Wistar Institute Cancer Center, University of Pennsylvania, Philadelphia, PA, USA Grigory Dianov, PhD, Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, UK Maurizio D’Incalci, MD, Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy Wei Du, PhD, Ben May Department for Cancer Research, UNiversity of Chicago, Chicago, IL, USA Zhen Fan, MD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Cristiano Ferlini, MD, PhD, Danbury Hospital Research Institute, Danbury, CT, USA Michael L. Freeman, PhD, Vanderbilt University School of Medicine, Nashville, TN, USA Simone Fulda, MD, PhD, Goethe-University Frankfurt, Germany Alfredo Fusco, MD, PhD, IEOS of the Consiglio Nazionale delle Ricerche, Napoli, Italy Carlo Gambacorti-Passerini, PhD, Department of Internal Medicine, University of Milano Bicocca, Monza, Italy Paramita Ghosh, PhD, Department of Urology, University of California, Davis, CA, USA Vincent Giguère, PhD, Goodman Cancer Research Centre, Montréal, QC, Canada Noriko Gotoh, MD, PhD, Institute of Medical Science, The University of Tokyo, Tokyo, Japan Hinrich Gronemeyer, PhD, Department of Cancer Biology at the IGBMC, Strasbourg, France Xin-Yuan Guan, PhD, Department of Clinical Oncology, University of Hong Kong, Hong Kong, China Philip Hahnfeldt, PhD, Center of Cancer Systems Biology, Tufts University School of Medicine, Boston, MA, USA Thomas Helleday, PhD, Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, UK Zdenko Herceg, PhD, International Agency for Research on Cancer (IARC), Lyon, France Courtney W. Houchen, MD, Oklahoma University, Oklahoma City, OK, USA Chiun Hsu, MD, PhD, National Taiwan University Hospital, Taipei, Taiwan Xianxin Hua, MD, PhD, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA Jiaoti Huang, MD, PhD, School of Medicine, University of California at Los Angeles, CA, USA Mong-Hong Lee, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Thomas Iftner, PhD, Virology Department, Eberhard-Karls University, Tuebingen, Germany Gang Li, MD, PhD, University of British Columbia, Vancouver, BC, Canada Su Hao Lo, PhD, Center for Tissue for Regeneration and Repair, University of California-Davis, Davis, CA, USA Hongchuan Jin, MD, PhD, Sir Runrun Shaw Hospital, Zhejiang University, Hangzhou, Zhejing, China Aart G. Jochemsen, PhD, Department of Molecular Cell Biology, Leiden University Medical Center, The Netherlands Shuichi Kaneko, MD, Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan Masashi Kato, MD, PhD, College of Life and Health Sciences, Chubu University, Kasugai-shi, Aichi, Japan Maria Kavallaris, PhD, Children’s Cancer Institute Australia, University of NSW, Sydney, Australia Kum Kum Khanna, PhD, Queensland Institute of Medical Research, Herston, Australia Hyeong-Reh Choi Kim, PhD, Wayne State University, Detroit, MI, USA Jae-Hong Kim, PhD, College of Life Sciences and Biotechnology, Korea University, Seoul, Korea

818

Am J Cancer Res 2011;1(6):817-822

Editorial Board 2011

Kyu-Won Kim, PhD, College of Pharmacy, Seoul NationaI University, Seoul, Korea Tohru Kiyono, MD, PhD, Virology Division, National Cancer Center Research Institute, Tokyo, Japan Margaret A. Knowles, PhD, Leeds University, Leeds, UK Hari K. Koul, PhD, University of Colorado Cancer Center, UCHSC, School of Medicine, Denver, CO, USA Richard Kremer, MD, PhD, McGill University, Montreal, Quebec, Canada Gopal C. Kundu, PhD, National Center for Cell Science, Pune, India Enzo Lalli, MD, IPMC CNRS, University of Nice-Sophia-Antipolis, Valbonne, France Pierre Laurent-Puig, MD, PhD, Paris Descartes Medical School, Paris Descartes University, Paris, France Horng-Mo Lee, PhD, Taipei Medical University, Taiwan Jeanette H.W. Leusen, PhD, Department of Immunology, University Medical Center Utrecht, the Netherlands Dan A. Liebermann, PhD, Temple University School of Medicine, Philadelphia, PA, USA Jiayuh Lin, PhD, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA Jean-Marc A. Lobaccaro, PhD, Clermont University, Clermont-Ferrand, France Peter E. Lobie, MD, PhD, Cancer Science Institute, National University of Singapore, Singapore Balakrishna L. Lokeshwar, PhD, Department of Urology and Radiation Oncology, University of Miami, Miami, FL, USA Bernard S. Lopez, PhD, Institut de radiobiologie cellulaire et moléculaire, Fontenay aux Roses, France Bo Lu, MD, PhD, Departments of Radiation Oncology and Cancer Biology, Vanderbilt University, Nashville, TN, USA Yong-Jie Lu, MD, PhD, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London Jianhua Luo, MD, PhD, Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA David J. MacEwan, PhD, School of Pharmacy, University of East Anglia, Norwich, UK Dario Marchetti, PhD, Baylor College of Medicine, Houston, TX, USA Clay B. Marsh, MD, Ohio State University, Columbus, OH Giovanni Melillo, MD, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD, USA Rosa Marina Melillo, MD, University of Naples Federico II, Naples, Italy Pablo Menendez, PhD, Andalusian Stem Cell Bank, University of Granada, Granada, Spain Dan Mercola, MD, PhD, University of California at Irvine, Irvine, CA, USA Do Sik Min, PhD, Department of Molecular Biology, College of Natural Science, Pusan National University, Korea Yin-Yuan Mo, PhD, Southern Illinois University School of Medicine, Springfield, IL, USA Elizabeth Moran, PhD, NJMS-UH Cancer Center, Newark, NJ, USA Catherine Muller, PhD, University of Toulouse III, Toulouse, France Markus Muschen, MD, PhD, University of California, San Francisco, USA Hiroshi Nakagawa, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA Karim Nayernia, PhD, Department of Stem Cell Biology, Newcastle University, Newcastle upon Tyne, UK Kirsten K. Ness, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA Agnès Noel, PhD, Molecular and Cellular Biology, University of Liège, Belgium Jacques E. Nor, DDS, PhD, University of Michigan Dental School, Ann Arbor, MI, USA Michael Ohh, PhD, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada Torben F. Orntoft, MD, MOMA, Aarhus University Hospital, Skejby, Denmark Sandra Orsulic, PhD, Women's Cancer Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA Ben Ho Park, MD, PhD, Johns Hopkins University, Baltimore, MD, USA Jong-Wan Park, MD, PhD, Seoul National University College of Medicine, Seoul, Korea Shazib Pervaiz, MD, PhD, National University of Singapore, Singapore-MIT Alliance, Singapore Godefridus J. Peters, PhD, Department Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands Valeria Poli, PhD, Molecular Biotechnology Center, University of Turin, Torino, Italy Aleksander S. Popel, PhD, Johns Hopkins University, Baltimore, MD, USA A. Postigo, MD,PhD, University of Barcelona School of Medicine, Barcelona, Spain Catrin Pritchard, PhD, University of Leicester, Leicester, UK M.R. Satyanarayana Rao, PhD, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India Francoise Redini, PhD, Institut National de la Sante et de la Recherche Medicale U957, Nantes, France Thomas Reinheckel, MD, PD, Albert-Ludwigs-University, Freiburg, Germany Pranela Rameshwar, PhD, UMDNJ-New Jersey Medical School, Newark, NJ, USA Ann Richmond, PhD, Vanderbilt Ingram Cancer Center, Nashville TN Serge Roche, PhD, University of Montpellier, Montpellier, France Hallgeir Rui, MD, PhD, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Fahri Saatcioglu, PhD, Department of Molecular Biosciences, University of Oslo, Oslo, Norway Fazlul H. Sarkar, PhD, Wayne State University, Detroit, MI, USA Simon Saule, PhD, Institut Curie UMR3347 CNRS, U1021 INSERM, Paris, France Nicholas A Saunders, PhD, Centre for Immunology and Cancer Research, University of Queensland, QLD, Australia David L. Schwartz, MD, Feinstein Institute for Medical Research, New Hyde Park, NY, USA Peter Shaw, PhD, Department of Biochemistry, University of Nottingham, Nottingham, UK Meng-Ru Shen, MD, PhD, Department of Obstetrics and Gynecology, National Cheng Kung University, Tainan, Taiwan Shigeomi Shimizu, MD, PhD, Tokyo Medical and Dental University, Tokyo, Japan

819

Am J Cancer Res 2011;1(6):817-822

Editorial Board 2011

Haval Shirwan, PhD, Institute for Cellular Therapeutics, University of Louisville, Louisville, KY, USA Vijayalakshmi (Viji) Shridhar, PhD, Mayo Clinic College of Medicine, Rochester, MN, USA Keshav K. Singh, PhD, Roswell Park Cancer Institute, Buffalo, NY, USA Rakesh K. Singh, PhD, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA Luis Souhami, MD, McGill University, Department of Radiation Oncology, Montreal, Canada Raymond L. Stallings, PhD, Cancer Genetics, Royal College of Surgeons in Ireland, Dublin 2, Ireland Shi-Yong Sun, PhD, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA Young-Joon Surh, MD, PhD, College of Pharmacy, Seoul National University, Seoul, South Korea Paul Szabolcs, MD, Department of Pediatrics and Immunology, Duke University Medical Center, Durham, NC, USA Michael A. Tainsky, PhD, Wayne State University School of Medicine, Detroit, MI, USA Yoh Takuwa, MD, PhD, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan Fuyu Tamanoi, PhD, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, CA, USA Mahvash Tavassoli, PhD, Department of Oncology, King's College London, London, UK Sam Thiagalingam, PhD, Department of Medicine, Boston University, Boston, MA, USA Hensin Tsao, MD, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Jaydutt V. Vadgama, PhD, UCLA School of Medicine, Los Angeles, CA, USA Ratna K. Vadlamudi, PhD, The University of Texas Health Science Center, San Antonio, TX, USA Peter Valent, MD, Medical University of Vienna, Austria Calvin P.H. Vary, PhD, Maine Medical Center Research Institute, Scarborough ME, USA David J. Waxman, PhD, Boston University, Boston, MA, USA David T. Weaver, PhD, On-Q-ity, Waltham, MA, USA Qingyi Wei, MD, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Elizabeth M. Wilson, PhD, University of North Carolina at Chapel Hill, NC, USA Stephen T. Wong, PhD, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, TX, USA Gutian Xiao, PhD, Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA Mingzhao Xing, MD, PhD, The Johns Hopkins University, Baltimore, MD, USA Liang Xu, MD, PhD, University of Kansas, Lawrence, KS, USA Masamitsu Yamaguchi, PhD, Department of Applied Biology, Kyoto Institute of Technology, Kyoto, Japan Vincent W. Yang, MD, PhD, Department of Hematology and Medical Oncology, Emory Univeraity, Atlanta, GA, USA Yun Yen, MD, PhD, City of Hope, Duarte, CA, USA Eldad Zacksenhaus, PhD, Department of Medicine, University of Toronto, Toronto, Canada Wenxin Zheng, MD, Department of Pathology and Gynecology, College of Medicine, University of Arizona, AZ, USA

Associate Editorial Board Fahd Al-Mulla, PhD, Faculty of Medicine, Kuwait University, Kuwait Ahmed Ashour Ahmed, MD, PhD, Gray Institute of Radiation Oncology and Biology, University of Oxford, Oxford, UK Matthew l. Anderson, MD, PhD, Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, USA Eran Andrechek, PhD, Michigan State University, East Lansing, MI, USA Nathalie Andrieu-Abadie, PhD, Department Epithelial Cancers, Angiogenesis and Signaling, Toulouse Cedex, France Rami I. Aqeilan, PhD, The Hebrew University-Hadassah Medical School, Jerusalem, Israel Andreas G. Bader, PhD, Mirna Therapeutics, Inc. Austin, TX, USA Véronique Baron, PhD, Vaccine Research Institute, San Diego, CA, USA Lisa D. Belmont, PhD, Research Oncology, Genentech, Inc. South San Francisco, CA, USA R. Daniel Bonfil, PhD, Departments of Urology and Pathology, Wayne State University, Detroit, MI, USA Habib Boukerche, PhD, INSERM-Faculty of Medicine René laennec, Lyon, France G. Steven Bova, MD, Johns Hopkins University School of Medicine, Bethesda, MD, USA Laura Bracci, PhD, Istituto Superiore di Sanità, Rome, Italy. Claudio Brancolini, PhD, Department of Biomedical Science, Medical School University of Udine, Udine, Italy Weibo Cai, PhD, University of Wisconsin, Madison, WI, USA Franco Capozza, PhD, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Mathias Chamaillard, PhD, Institut de Biologie de Lille, Lille cedex, France Ceshi Chen, PhD, Center for Cell Biology and Cancer Research, Albany Medical College, Albany, NY, USA Jian-Wei Chen, PhD, Institute of Biomedical Sciences, National Chung Hsing University, Taiwan Arnold Chin, MD, PhD, Department of Urology, University of California at Los Angeles, Los Angeles, CA, USA Victoria Cowling, PhD, College of Life Sciences, University of Dundee, Dundee, UK Qi Dai, MD, PhD, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA Giovanna Damia, MD, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy Asit K. De, PhD, University of Rochester Medical Center, Rochester, NY, USA

820

Am J Cancer Res 2011;1(6):817-822

Editorial Board 2011

Sandro De Falco, PhD, Institute of Genetics and Biophysics “A. Buzzati Traverso", CNR, Napoli, Italy Paola Defilippi, PhD, Department of Cell Biology, University of Torino, Torina, Itlay Roberto Diaz, MD, PhD, Department of Radiation Oncology, Emory University, Atlanta, GA, USA Mojgan Djavaheri-Mergny, PhD, INSERM U916 VINCO, Institut Bergonié, Bordeaux, France Massimo Dominici, MD, Department of Oncology, University Hospital of Modena and Reggio Emilia, Modena , Italy Ronny Drapkin, MD, PhD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Dan G. Duda, PhD, Massachusetts General Hospital, Harvard University, Boston, MA, USA Sonia A. Duffy, PhD, Department of Otolaryngology and Psychiatry, University of Michigan, Ann Arbor, MI, USA Nelson Dusetti, PhD, INSERM, U624 Stress cellulaire, Aix-Marseille Université, Marseille, France Martin Dutertre, PhD, National Institute of Health and Medical Research, Lyon, France Mohamed El-Tanani, PhD, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK Heidi S. Erickson, PhD, University of Texas MD Anderson Cancer Center, Houston TX, USA Lluís Espinosa, PhD, Cancer Research Program, IMIM-Hospital del Mar, Barcelona. Spain Alessandro Fatatis, MD, PhD, Drexel University College of Medicine, Philadelphia, PA, USA Rati Fotedar, PhD, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA Markus H. Frank, MD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Liwu Fu, MD, PhD, Cancer Institute, Sun Yat-sen University, Guangzhou, China Rossella Galli, PhD, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy. Francois Ghiringhelli, MD, PhD, International Union Against Cancer, Dijon, France Hava Gil-Henn, PhD, Yale University School of Medicine, New Haven, CT, USA Olivier Gires, PhD, Department of Head and Neck Research, Ludwig-Maximilians-University, Munich, Germany Ajay Goel, PhD, Gastrointestinal Cancer Research Laboratory, Baylor University Medical Center, Dallas, TX, USA Brigitte N. Gomperts, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Rajgopal Govindarajan, PhD, University of Georgia, Athens, GA, USA Bin Guo, PhD, College of Pharmacy, North Dakota State University, Fargo, ND, USA Zong Sheng Guo, PhD, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA Ester Hammond, PhD, Gray Institute for Radiation Oncology and Biology, Oxford University, London UK Eva M Harth, PhD, Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, TN, USA David “Neil” Hayes, MD, Lineberger Comprehensive Cancer Center, University of North Corolina, Chapel Hill, NC, USA Jiang He, PhD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Ming Liang He, PhD, The Chinese University of Hong Kong, Hong Kong, China Yu-Ying He, PhD, Department of Medicine, University of Chicago, Chicago, IL, USA Sheri Holmen, PhD, Drug Development, Nevada Cancer Institute, Las Vegas, NV, USA Elizabeth Hopper-Borge, PhD, Fox Chase Cancer Center, Philadelphia, PA, USA Michael Hsiao DVM, PhD, Genomics Research Center, Academia Sinica, Taiwan Chang-Deng Hu, MD, PhD, College of Pharmacy, Purdue University, West Lafayette, IN, USA Annie Huang, MD, PhD, Arthur and Sonia Labatt Brain Tumor Research Centre, University of Toronto, Canada Bo Huang, PhD, MD, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Paul H. Huang, PhD, The Institute of Cancer Research, London, UK Peter Igaz, MD, PhD, Faculty of Medicine, Semmelweis University, Budapest, Hungary Gareth J. Inman, PhD, The Biomedical Research Institute, University of Dundee, Dundee, UK Jennifer Isaacs, PhD, Medical University of South Carolina, Charleston, SC, USA Sebastien Jauliac, PhD, Université Paris Diderot, Institut d'Hématologie,Paris Cedex, France Ali Jazirehi, PhD, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA Hong Jiang, PhD, University of Texas MD Anderson Cancer Center, Houston TX, USA Li Jiao, MD, PhD, Baylor College of Medicine, Houston, TX, USA Donald J. Johann, Jr., MD, National Cancer Institute, Maryland, MD, USA Tanya Kalin, MD, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Gudrun Koehl, PhD, Department of Surgery, University Hospital Regensburg, Regensburg, Germany Xiang-Ping Li, MD, PhD, Nanfang Hospital, Southern Medical University, Guangzhou, China Zhihua Liu, PhD, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Othon Iliopoulos, MD, Massachusetts General Hospital Cancer Center, Harvard University, Boston, MA, USA Tom Luedde, MD, PhD, University Hospital, RWTH Aachen, Aachen, Germany Samir Iqbal, PhD, The University of Texas at Arlington, TX, USA Kosaku Iwatsubo, MD, PhD, University of Medicine & Dentistry of New Jersey, Newark, NJ, USA Anjali Jain, PhD, David Geffen UCLA School of Medicine, University of California at Los Angeles, CA, USA Oliver Holger Krämer, PhD, Friedrich-Schiller University (FSU), Jena, Germany Nancy Y. Lee, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Sean Bong Lee, PhD, Genetic Disease Research Section, NIDDK, National Institutes of Health, Bethesda, MD, USA Yong Liao, MD, PhD, The University of Texas M.D. Anderson Cancer Center, Houston TX, USA Wolfgang Link, PhD, Spanish National Cancer Centre (CNIO) Madrid, Spain Bolin Liu, MD, University of Colorado School of Medicine, Denver, Denver, CO, USA

821

Am J Cancer Res 2011;1(6):817-822

Editorial Board 2011

Xiongbin Lu, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, USA John P. Lynch, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA Stephanie Ma, PhD, The University of Hong Kong, Hong Kong, China Barbara Majello, PhD, Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy. Zdravka O. Medarova, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Albert S Mellick, PhD, Griffith University, School of Medical Science, Queensland, Australia Daniel Monleon, PhD, Fundacion Investigacion Hospital Clinico Valencia, Incliva, Spain Federica Moschella, PhD, Istituto Superiore di Sanità, Rome, Italy Nasreen Najmunnisa, PhD, University of Florida, Gainesville, FL, USA Irina Nazarenko, PhD, Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany David M. Owens, PhD, Departments of Dermatology and Pathology, Columbia University, New York, NW, USA François E. Paris, PhD, Centre de Recherche en Cancérologie, Nantes, France Chris Parsons, MD, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA Dmitry Pshezhetskiy, PhD, Department of Surgery and Cancer, Imperial College London, London, UK Alain Piche, MD, Department of Microbiology & Infect. Disease, University of Sherbrooke, Sherbrooke, Canada Patrick J. Pollard, PhD, Nuffield Department of Medicine, University of Oxford, Oxford, UK Venuprasad K. Poojary, PhD, Departments of Oncology, Wayne State University, Detroit, MI, USA David Z. Qian, PhD, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA Prahlad T. Ram, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Gary W. Reuther, PhD, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA Jean-Ehrland Ricci, PhD, Batiment Universitaire Archimed, NICE Cedex, France Palma Rocchi, PhD, Inserm U624 "cellular stress", Parc Scientifique et Technologique de Luminy, Marseille, France Ignacio Perez Roger, PhD, University of CEU-Cardenal Herrera, Valencia, Spain Devanand Sarkar, PhD, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA Yuval Shaked, PhD, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel Farbod Shojaei, PhD, Pfizer Global R&D, San Diego, CA, USA Christian Simon, PhD, Department of Otorhinolaryngology, University of Heidelberg, Heidelberg, Germany Keiran S. Smalley, PhD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA Claudio Sorio, MD, PhD, University of Verona School of Medicine, Verona, Italy Monique A. Spillman, MD, PhD, University of Colorado, Aurora, CO, USA Lesley Stark, PhD, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK Eitan Shaulian, PhD, The Hebrew University Medical School, Jerusalem , Israel Subbaya Subramanian, PhD, University of Minnesota, Minneapolis, MN, USA Michael Tangrea, PhD, National Cancer Institute, Gaithersburg, MD, USA Francoise Thierry, PhD, Institute of Medical Biology, Singapore Stephen H. Thorne, PhD, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA Stephan Vagner, PhD, INSERM U981, Institut Gustave Roussy, Villejuif, France Jean-Baptiste Vincourt, PhD, Faculty of Medicine, University Henri Poincaré, doeuvre Cedex, France Chenguang Wang, PhD, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA Jenny Wang, PhD, University of Nebraska Medical Center, Omaha, NE, USA Ralph Wasch, MD, Department of Hematology and Oncology, University Medical Center, Freiburg, Germany Wenyi Wei, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Ben Wielockx, PhD, Dresden University of Technology, Dresden, Saxony, Germany Jörg Wischhusen, PhD, Interdisciplinary Center for Clinical Research, University of Würzburg, Würzburg, Gemany Guojun Wu, PhD, Karmanos Cancer Institite, Wayne State University, Detroit, MI, USA Yun Wu, MD, PhD, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Wei Xu, PhD, University of Wisconsin, Madison, USA Taro Yamashita, MD, PhD, Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan Rozita Yarmand-Bagheri, PhD, The University of Texas MD Anderson Cancer Center,, Houston, TX, USA Jose Yelamos, PhD, Department of Immunology, IMIM-Hospital del Mar, Barcelona, Spain Zhong Yun, PhD, Department of Therapeutic Radiology, Yale University, New Haven, CT, USA Qi Zeng, PhD, Institute of Molecular and Cellular Biology, A*STAR, Singapore Bin Zhang, MD, PhD, Cancer Therapy & Research Center, University of Texas, San Antonio, TX, USA Jennifer Y. Zhang, PhD, Department of Dermertalogy, Duke University, Durham, NC, USA Wenzheng Zhang, PhD, University of Texas, Houston, TX, USA Yangbing Zhao, MD, PhD, University of Pennsylvania, Philadelphia, PA, USA

822

Am J Cancer Res 2011;1(6):817-822